CoMentis, Inc. is a company that provides Lampalizumab, Angiogenesis inhibitor, Small molecule and more. CoMentis, Inc. is headquartered in United States California. CoMentis, Inc. was founded in 2004. CoMentis, Inc. has a total of 110 patents
CoMentis is a biotech company focused on the research and development of small molecule drugs to treat neurovascular diseases such as Alzheimer's disease...